Mandate

Vinge advises Öhman, Procuritas, Spiltan and others in connection with the acquisition of 51.1 per cent of the shares in Emric AB

June 10, 2010

Vinge is advising KB Götaberg 20 (Öhman), Investmentbolaget av 1 maj 2009 AB (Procuritas), Investment AB (Spiltan), Norra Brofästet i Sundsvall AB and F. Månsson Invest AB in connection with the acquisition of 50.1 per cent of the shares in Emric AB from Bisnode AB. Emric is one of Sweden's leading providers of software, expert consultancy and outsourcing services to the banking and financial services sector. The acquisition is based on a call option which was issued in connection with Bisnode's purchase of 50.1 per cent of the shares in Emric in 2007.
 
Vinge's team advising the buyers consists of partner Henrik Wenckert and associates Marie Brommesson and Peter Sundgren.

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024